Rallybio Corporation RLYB
15.76 USD +0.10 (+0.64%)
At closeNov 10, 2026, 4:00 PM EST
15.70 -0.06 -0.38%
After hours · Nov 10, 4:00 PM ET
15.32 Day range 15.76
3.67 52-week range 17.57
- YTD
- +187.07%
- 1 year
- +203.08%
News
businesswire.com Rallybio Announces Reverse Stock Split of Common Stock in Connection with the Proposed Merger with Avenzo EAST BERLIN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced that it will effect a one-for-two reverse stock split of its issued and outstanding common stock in connection…
marketbeat.com Rallybio Stockholders Approve Avenzo Merger, Name Change and Reverse Split Rallybio NASDAQ: RLYB stockholders approved a series of proposals tied to the company's planned merger with Avenzo Therapeutics Inc., including the issuance of Rallybio shares to Avenzo security…
benzinga.com Rallybio Q3 EPS $(0.48) Misses $(0.21) Estimate Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.21) by 128.57 percent. This is a 57.14 percent increase over losses of $(1.12)…
benzinga.com Rallybio Declares $82.7M Special Cash Distribution To Stockholders And Pre-Funded Warrant Holders, Estimated At $13.56/Share, In Connection With Avenzo Therapeutics Merger As previously disclosed, on May 31, 2026, the Rallybio Corporation, a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement")…